The Weed Care research, a large-scale scientific endeavor in Switzerland, has been investigating the effects of legal cannabis access on usage trends and mental health consequences since January 2023. The goal of this project, which is being led by a consortium comprising the University of Basel, the University Psychiatric Clinics Basel, Psychiatric Services Aargau, and the Addiction Department of the Canton of Basel-Stadt, is to give continuing discussions about the legalization of cannabis a strong scientific basis.
The study team’s first significant findings were published in the journal Addiction on May 8, 2025. Their findings make a strong argument: legal cannabis access may even lower problematic consumption, especially among some high-risk groups, and does not increase use or related mental health problems.
Context: public health issues and legalization discussions
There has long been a mixture of optimism and hesitancy surrounding discussions over the legalization of cannabis in Switzerland and other nations. Legalization, according to supporters, may guarantee access to safer products, assist end the illegal market, and link consumers with health services that encourage low-risk consumption. However, detractors fear that legalization may normalize and promote use, which could increase the prevalence of addiction and mental health issues.
Rather than depending solely on conjecture or observational data, the Weed Care project is intended to thoroughly examine these hypotheses. This is the first randomized, controlled research to examine the consequences of legal cannabis availability in such detail, according to Dr. Lavinia Baltes-Flückiger, the report’s primary author and the study’s deputy head.
Researchers randomly split approximately 370 individuals into two groups during the study’s first six months. One group received optional therapy and accessed cannabis legally through nine approved pharmacies. The other group continued to unlawfully obtain cannabis, primarily from the underground market.
Participants routinely completed surveys about cannabis use and mental health. This arrangement allowed researchers to directly compare the consumption patterns and psychological health of people with legal and illicit access.
A decrease in problematic consumption is the main finding
The study’s most significant findings link legal availability of cannabis to a minor decline in problematic usage. A use that does not fit the criteria for clinical addiction still qualifies as “problematic consumption” if it leads to social, psychological, or bodily issues. Those who reported taking other substances in addition to cannabis showed a particularly strong decrease in hazardous usage. Legal availability led to a notable decrease in cannabis abuse in this population. Dr. Baltes-Flückiger underlined the significance of this discovery, pointing out that it may help guide future harm-reduction tactics that are more focused.
No symptoms have worsened. Mental health results are positive. Many worry that better access to cannabis could worsen mental health issues. Anxiety and depression are major concerns for those opposed to legalization. The study found no significant changes. This was true for psychological symptoms. Anxiety and depression showed no difference. The two groups remained similar over the first six months.
This discovery is important. It eases worries. Legalization may not worsen mental health issues linked to cannabis. It suggests that users might experience fewer negative effects in a controlled system. This could be due to safer drugs or access to counseling.
Lasting benefits: reduced pressure
As first promised, the original control group was likewise given legal access after six months. An intermediate evaluation with about 300 surviving participants as the trial began its second year revealed significant gains in mental health overall.
“Legal access eases the burden on consumers,” said Professor Marc Walter, the primary investigator of the study from the University of Basel. He attributes these advancements to the methodical, health-focused legalization approach.
Policy implications: a legal framework focused on health
The Weed Care study shows clear results. Legalization does not lead to more harm. It does not increase cannabis use when approached with a public health focus. On the other hand, it could provide real benefits. This is especially true for those already at risk. They may be using other drugs at the same time.
Researchers found that public health regulation could make cannabis safer. It may be an effective policy model. As cannabis policy evolves, these findings offer clear recommendations. They are for legislators, medical professionals, and the public. Switzerland’s study makes a strong case. It supports a careful, health-focused method for cannabis legalization. This approach can reduce harm and enhance user outcomes.